The US market for Hemostats and Sealants came roaring back from its pandemic depths in Q221 as procedures returned to normal.
As surgical procedures returned to approximately normal levels, the US Hemostats and Sealants market grew +51.1% YoY in Q221 according to SmartTRAK Financial Dashboard. Growth was strong across all segments and companies. However, the Delta variant may make that recovery short-lived, as recently observed in Texas.
Among the many topics covered in detail in our comprehensive Q221 US Hemostats and Sealants Market Recap* are:
- Complete Q221 US Hemostats & Sealants Market Overview
- SmartTRAK's Expert Analysis and Insights
- All H&S News including Revenues, Data, Charts and Shares
- US Hemostats and Sealants Market Resumes Growth
- Strength Across Hemostats
- Sealants Come Back
- Important Q221 Events
JNJ/Ethicon* pulled ahead in the US Hemostats and Sealants market in Q221 notching growth of +49.1% YoY as procedures recovered. Second-place Baxter* saw an even larger gain while Becton Dickinson* (BD) remained in ...
Read the entire Q221 US Hemostats and Sealants Market Recap, including news, data, charts, company revenues, shares and our expert analysis*
*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
SmartTRAK has recently expanded it's coverage to include five new modules.
Click to see details of all the exciting new additions to the
SmartTRAK platform in 2021.